Skip to main content
Top
Published in: Supportive Care in Cancer 9/2014

01-09-2014 | Original Article

The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management

Authors: Carrie J. Aigner, Mike Hernandez, Lakshmi Koyyalagunta, Diane Novy

Published in: Supportive Care in Cancer | Issue 9/2014

Login to get access

Abstract

Purpose

Psychological symptoms are a common part of the cancer pain experience, yet little is known about how these factors relate to implantable device outcomes in patients with cancer pain. The purpose of this study was to examine how psychological symptoms relate to implantable device outcomes in cancer pain management.

Methods

We retrospectively examined the medical records of 79 cancer patients, collecting information on psychological symptoms and pain, as assessed on the Edmonton Symptom Assessment System. Data were collected prior to and at three points following the implantation of either a spinal cord stimulator or an intrathecal pump.

Results

Pain was correlated with both anxiety, r = 0.39 (n = 74, p < 0.01), and depression, r = 0.38, (n = 75, p < 0.01), at the presurgery baseline. Results of linear mixed model (LMM) analysis indicated that neither baseline anxiety nor baseline depression main effects were significantly associated with pain at postimplant assessments, when adjusting for baseline pain, demographics, and clinical factors. However, the group-by-time interaction was significant for anxiety (beta = 0.223, p value = 0.037). The trajectory of pain scores over time differed by baseline anxiety scores, with pain scores increasing over time at a higher rate for those with a high baseline anxiety score, compared to those with low baseline anxiety scores.

Conclusion

Presurgery psychological symptoms should be considered, along with other medical, psychosocial, and individual characteristics in multidisciplinary treatment planning. Multidisciplinary care which includes aspects of mood management or supportive psychotherapy would likely be beneficial to cancer patients presenting with high psychological symptoms.
Literature
1.
go back to reference Deer TS, Smith HS, Burton A, Pope J, Doleys D, Levy R, Staats P, Wallace M, Webster L (2011) Comprehensive consensus based guildelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 14:E283–E312PubMed Deer TS, Smith HS, Burton A, Pope J, Doleys D, Levy R, Staats P, Wallace M, Webster L (2011) Comprehensive consensus based guildelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 14:E283–E312PubMed
2.
go back to reference Stojanovic M, Abdi S (2002) Spinal cord stimulatin. Pain Physician 5(2):156–166PubMed Stojanovic M, Abdi S (2002) Spinal cord stimulatin. Pain Physician 5(2):156–166PubMed
3.
go back to reference Burchiel K, Anderson V, Brown F, Fessler R (1996) Prospective multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 23:2786–2794CrossRef Burchiel K, Anderson V, Brown F, Fessler R (1996) Prospective multicenter study of spinal cord stimulation for relief of chronic back and extremity pain. Spine 23:2786–2794CrossRef
4.
go back to reference Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante M (2000) Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manag 20(2):S12–S35CrossRef Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante M (2000) Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manag 20(2):S12–S35CrossRef
5.
go back to reference Middel B, Kuipers-Upmeijer H, Bouma J, Stall M (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204–209PubMedCentralPubMedCrossRef Middel B, Kuipers-Upmeijer H, Bouma J, Stall M (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63:204–209PubMedCentralPubMedCrossRef
6.
go back to reference Syrjala K, Chapko M (1995) Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 61:69–79PubMedCrossRef Syrjala K, Chapko M (1995) Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 61:69–79PubMedCrossRef
7.
go back to reference Burchiel K, Anderson V, Wilson BJ, Denison D, Olson K, Shatin D (1995) Prognostic factors of spinal cord stimulation for chronic back and leg pain. Neurosurgery 36:1101–1111PubMedCrossRef Burchiel K, Anderson V, Wilson BJ, Denison D, Olson K, Shatin D (1995) Prognostic factors of spinal cord stimulation for chronic back and leg pain. Neurosurgery 36:1101–1111PubMedCrossRef
8.
go back to reference Olson K, Bedder M, Anderson V, Burchiel K, Villanueva M (1995) Psychological variables associated with outcome in spinal cord stimulation trials. Clin J Pain 17:155–161 Olson K, Bedder M, Anderson V, Burchiel K, Villanueva M (1995) Psychological variables associated with outcome in spinal cord stimulation trials. Clin J Pain 17:155–161
9.
go back to reference Heckler D, Gatchel R, Lou L, Whitworth T, Bernstein D, Stowell A (2007) Presurgical behavioral medicine evaluation (PBME) for implantable devices for pain management: a 1-year prospective study. Pain Pract 7(2):110–122PubMedCrossRef Heckler D, Gatchel R, Lou L, Whitworth T, Bernstein D, Stowell A (2007) Presurgical behavioral medicine evaluation (PBME) for implantable devices for pain management: a 1-year prospective study. Pain Pract 7(2):110–122PubMedCrossRef
10.
go back to reference Prager J, Jacobs M (2001) Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin J Pain 17:206–214PubMedCrossRef Prager J, Jacobs M (2001) Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin J Pain 17:206–214PubMedCrossRef
11.
go back to reference Deer T, Smith H, Cousins M, Doleys D, Levy R, Rathmell J, Staats P (2010) Consensus guidelines for the selection and implantation of patients with noncancer pain for intratecal drug delivery. Pain Physician 13:E175–E213PubMed Deer T, Smith H, Cousins M, Doleys D, Levy R, Rathmell J, Staats P (2010) Consensus guidelines for the selection and implantation of patients with noncancer pain for intratecal drug delivery. Pain Physician 13:E175–E213PubMed
12.
go back to reference Nelson D, Kennington M, Novy D, Squitieri P (1996) Psychosocial selection criteria for implantable spinal cord stimulators. Pain Forum 52(2):93–103CrossRef Nelson D, Kennington M, Novy D, Squitieri P (1996) Psychosocial selection criteria for implantable spinal cord stimulators. Pain Forum 52(2):93–103CrossRef
13.
go back to reference Beltrutti D, Lamberto A, Barolat G, Bruehl S, Doleys D, Krames E, Meglio M, North R, Olson K, Reig E, Melzack R (2004) The psychological assessments of candidates for spinal cord stimulation for chronic pain management. Pain Pract 4(3):204–221PubMedCrossRef Beltrutti D, Lamberto A, Barolat G, Bruehl S, Doleys D, Krames E, Meglio M, North R, Olson K, Reig E, Melzack R (2004) The psychological assessments of candidates for spinal cord stimulation for chronic pain management. Pain Pract 4(3):204–221PubMedCrossRef
14.
go back to reference Lechnyr T (2009) Pre-implant psychological evaluations. Practical Pain Management (January/February) Lechnyr T (2009) Pre-implant psychological evaluations. Practical Pain Management (January/February)
15.
go back to reference Ahmed S, Martin N, Chang Y (2005) Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey. Neuromodulation 8(2):112–120PubMedCrossRef Ahmed S, Martin N, Chang Y (2005) Patient selection and trial methods for intraspinal drug delivery for chronic pain: a national survey. Neuromodulation 8(2):112–120PubMedCrossRef
16.
go back to reference Sellick S, Crooks D (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychosocial interventions. Psycho-Oncology 8:315–333PubMedCrossRef Sellick S, Crooks D (1999) Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychosocial interventions. Psycho-Oncology 8:315–333PubMedCrossRef
17.
go back to reference Delgado-Guay M, Parson H, Li Z, Palmer J, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–579PubMedCrossRef Delgado-Guay M, Parson H, Li Z, Palmer J, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–579PubMedCrossRef
18.
go back to reference Gao W, Bennett M, Stark D, Murray S, Higginson I (2010) Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer 46(11):2036–2044PubMedCrossRef Gao W, Bennett M, Stark D, Murray S, Higginson I (2010) Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer 46(11):2036–2044PubMedCrossRef
19.
go back to reference Chang V, Shirley H, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef Chang V, Shirley H, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef
20.
go back to reference Jensen M (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21PubMedCrossRef Jensen M (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21PubMedCrossRef
21.
go back to reference Holen J, Lydersen S, Klepstad P, Loge J, Kaasa S (2008) The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 24:219–225PubMedCrossRef Holen J, Lydersen S, Klepstad P, Loge J, Kaasa S (2008) The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 24:219–225PubMedCrossRef
22.
go back to reference Cleeland C (2009) The Brief Pain Inventory user guide. MD Anderson Cancer Center, Houston Cleeland C (2009) The Brief Pain Inventory user guide. MD Anderson Cancer Center, Houston
23.
go back to reference Fitzgerald P, Lo C, Li M, Gagliese L, Zimmerman C, Rodin G (2013) The relationship between depression and physical symptom burden in advanced cancer. BMJ Supportive and Palliative Care 0:1–8 Fitzgerald P, Lo C, Li M, Gagliese L, Zimmerman C, Rodin G (2013) The relationship between depression and physical symptom burden in advanced cancer. BMJ Supportive and Palliative Care 0:1–8
24.
go back to reference Galloway S, Baker M, Giglio P, Chin S, Madan A, Malcolm R, Serber E, Wedin S, Balliet W, Borckardt J (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:1–4CrossRef Galloway S, Baker M, Giglio P, Chin S, Madan A, Malcolm R, Serber E, Wedin S, Balliet W, Borckardt J (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:1–4CrossRef
25.
go back to reference Zoega S, Fridriksdottir N, Sigurdardottir V, Gunnarsdottir S (2013) Pain and other symtoms and their relationship to quality of life in cancer patients on opioids. Qual Life Res 22:1273–1280PubMedCrossRef Zoega S, Fridriksdottir N, Sigurdardottir V, Gunnarsdottir S (2013) Pain and other symtoms and their relationship to quality of life in cancer patients on opioids. Qual Life Res 22:1273–1280PubMedCrossRef
26.
go back to reference Molloy AN, Nicholas MK, Asghari A, Beeston L, Dehghani M, Cousins M, Brooker C, Tonkin L (2006) Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination. Pain Pract 6(2):96–103PubMedCrossRef Molloy AN, Nicholas MK, Asghari A, Beeston L, Dehghani M, Cousins M, Brooker C, Tonkin L (2006) Does a combination of intensive cognitive-behavioral pain management and a spinal implantable device confer any advantage? A preliminary examination. Pain Pract 6(2):96–103PubMedCrossRef
Metadata
Title
The association of presurgery psychological symptoms with postsurgery pain among cancer patients receiving implantable devices for pain management
Authors
Carrie J. Aigner
Mike Hernandez
Lakshmi Koyyalagunta
Diane Novy
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2219-y

Other articles of this Issue 9/2014

Supportive Care in Cancer 9/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine